好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Vascular Cognitive Impairment and Dementia: Current Status and Future

Saturday 03/23/13
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Larry B. Goldstein, MD, FAHA, FAAN
Aging/Dementia/Degenerative Disease
Participants should be able to discuss issues related to the diagnosis of vascular dementia and its overlap with dementia related to nonvascular causes; discuss the epidemiology of and current treatment strategies for VCI and dementia; describe developments designed to provide a uniform approach to the assessment of patients with VCI and dementia; and discuss new efforts to understand the mechanisms of VCI and dementia, as well as ongoing and future research into its prevention and treatment.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Interactive

Program Evaluations

Event Timeline
06:30 AM - 07:05 AM VCI/Dementia—Where Are We Now?
Larry B. Goldstein, MD, FAHA, FAAN
06:30 AM - 08:30 AM Break
07:05 AM - 07:20 AM Topic Discussion
Larry B. Goldstein, MD, FAHA, FAAN
07:20 AM - 07:55 AM VCI/Dementia—Where Are We Going?
David S. Knopman, MD, FAAN
07:55 AM - 08:10 AM Topic Discussion
David S. Knopman, MD, FAAN
08:10 AM - 08:30 AM General Discussion—Example Case
Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.